| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
169,410,000 |
| Market
Cap: |
97.83(M) |
| Last
Volume: |
3,856,623 |
Avg
Vol: |
3,845,860 |
| 52
Week Range: |
$0.35 - $0.885 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
5,700 |
49,676 |
| Total Sell Value |
$0 |
$0 |
$3,192 |
$85,601 |
| Total People Sold |
0 |
0 |
1 |
3 |
| Total Sell Transactions |
0 |
0 |
1 |
7 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kies Peter |
CFO |
• – – |
2021-01-15 |
4 |
AS |
$10.02 |
$300,558 |
D/D |
(30,000) |
119,290 |
|
-22% |
|
| Kies Peter |
CFO |
• – – |
2021-01-15 |
4 |
OE |
$4.56 |
$136,800 |
D/D |
30,000 |
149,290 |
|
- |
|
| Zoth Lota S |
Director |
– • – |
2021-01-05 |
4 |
AS |
$9.48 |
$9,110 |
D/D |
(961) |
15,232 |
|
-29% |
|
| Benito Simon X |
Director |
– • – |
2021-01-04 |
4 |
AS |
$9.00 |
$24,750 |
D/D |
(2,750) |
51,650 |
|
-36% |
|
| Benito Simon X |
Director |
– • – |
2021-01-04 |
4 |
OE |
$3.56 |
$9,790 |
D/D |
2,750 |
54,400 |
|
- |
|
| Zoth Lota S |
Director |
– • – |
2021-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
16,193 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2020-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
1,178,313 |
|
- |
|
| Weiner David B. |
Director |
– • – |
2020-12-15 |
4 |
AS |
$10.71 |
$187,352 |
D/D |
(17,500) |
827,219 |
|
-34% |
|
| Weiner David B. |
Director |
– • – |
2020-12-15 |
4 |
OE |
$4.56 |
$79,800 |
D/D |
17,500 |
844,719 |
|
- |
|
| Kies Peter |
CFO |
• – – |
2020-12-15 |
4 |
AS |
$10.69 |
$213,706 |
D/D |
(20,000) |
119,290 |
|
-34% |
|
| Kies Peter |
CFO |
• – – |
2020-12-15 |
4 |
OE |
$2.16 |
$45,300 |
D/D |
20,000 |
139,290 |
|
- |
|
| Yarno Wendy L |
Director |
– • – |
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
28,453 |
|
- |
|
| Humeau Laurent |
Chief Scientific Officer |
• – – |
2020-11-10 |
4 |
AS |
$9.75 |
$189,794 |
D/D |
(19,466) |
24,500 |
|
-17% |
|
| Humeau Laurent |
Chief Scientific Officer |
• – – |
2020-08-10 |
4 |
AS |
$19.06 |
$371,004 |
D/D |
(19,467) |
43,966 |
|
-46% |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2020-07-30 |
4 |
AS |
$21.13 |
$2,113,450 |
D/D |
(100,000) |
1,188,313 |
|
-45% |
|
| Kies Peter |
CFO |
• – – |
2020-07-15 |
4 |
AS |
$24.95 |
$873,208 |
D/D |
(35,000) |
119,290 |
|
-59% |
|
| Kies Peter |
CFO |
• – – |
2020-07-15 |
4 |
OE |
$2.40 |
$84,000 |
D/D |
35,000 |
154,290 |
|
- |
|
| Kies Peter |
CFO |
• – – |
2020-06-30 |
4 |
AS |
$26.50 |
$927,500 |
D/D |
(35,000) |
119,290 |
|
-57% |
|
| Humeau Laurent |
Chief Scientific Officer |
• – – |
2020-06-22 |
4 |
AS |
$14.70 |
$286,165 |
D/D |
(19,467) |
63,433 |
|
-35% |
|
| Benito Simon X |
Director |
– • – |
2020-05-20 |
4 |
S |
$15.95 |
$139,594 |
D/D |
(8,750) |
51,650 |
|
26% |
|
| Benito Simon X |
Director |
– • – |
2020-05-20 |
4 |
OE |
$4.60 |
$40,250 |
D/D |
8,750 |
60,400 |
|
- |
|
| Weiner David B. |
Director |
– • – |
2020-05-11 |
4 |
AS |
$11.84 |
$28,463 |
D/D |
(2,404) |
827,219 |
|
49% |
|
| Weiner David B. |
Director |
– • – |
2020-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,013 |
829,623 |
|
- |
|
| Yarno Wendy L |
Director |
– • – |
2020-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,013 |
24,363 |
|
- |
|
| Zoth Lota S |
Director |
– • – |
2020-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,013 |
12,103 |
|
- |
|
488 Records found
|
|
Page 7 of 20 |
|
|
